Sponsored

Creso to Acquire Halucenex - Stock Market News - Kalkine Media

The big news in Australia Stock Market is Creso Pharma to acquire Halucenex Life Sciences. Creso Pharma is engaged in the development of cannabis and hemp-derived therapeutic, nutraceutical, and lifestyle products. Earlier this week the Company announced the acquisition of psychedelics company, Halucenex Life Sciences. Here, Mr Bruce Linton, Creso Strategic Advisor, talks about the deal, the optimism surrounding it, and what could it mean for the Company. To know more about that watch this video.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK